$64.16 0.28 (+0.44%)
12/3/2009 4:00 PM

Johnson & Johnson (JNJ)

CAPS Rating: 5 out of 5

Engaged in the research and development, manufacture and sale of a range of products in the health care field in many countries of the world.

Recs

1
Member Avatar SafeAndCheap (99.49) Submitted: 9/21/2008 9:19:46 PM : Outperform Start Price: $61.00 JNJ Score: +22.80

I don't like investing in individual pharma companies as a rule: too much risk in any individual company. J&J is the exception; it's a bit like owning a pharma ETF. Plus it's one of the world's better run companies. You won't hit a home run, but with reinvested dividends, you'll earn a respectable return over time. Sleep at night with J&J.

Report this Post 0 Comments

Featured Broker Partners